are they stopping compounded tirzepatide June/July 2026 Changes to Tirzepatide

doi: 10.1152/ajpgi.00453.2006 64 KoehlerJABaggioLLYustaBLonguetCRowlandKJCaoXet al

Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus

Additionally, patients experiencing severe or persistent gastrointestinal side effectsincluding nausea, vomiting, diarrhea, or abdominal painshould not attempt to self-manage these symptoms, as they may indicate pancreatitis, gallbladder disease (right upper quadrant pain, fever, jaundice), or other serious adverse effects requiring immediate evaluation

Studies published in obesity journals confirm that 70% of patients regain significant weight within 12 months of discontinuation, with many returning to baseline within 18-24 months